VentriPoint Diagnostics Ltd. (VPTDF)
USD 0.07
(-2.72%)
USD 0.07
(-2.72%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 42.43 Thousand CAD | -141.92% |
| 2022 | 57.8 Thousand CAD | 218.43% |
| 2021 | -48.81 Thousand CAD | -285.81% |
| 2020 | 26.27 Thousand CAD | -29.33% |
| 2019 | 37.17 Thousand CAD | 41.88% |
| 2018 | 26.19 Thousand CAD | 2490.33% |
| 2017 | -1096.00 CAD | 96.03% |
| 2016 | -27.63 Thousand CAD | -103.21% |
| 2015 | -13.6 Thousand CAD | -152.24% |
| 2014 | 26.03 Thousand CAD | 199.09% |
| 2013 | -26.27 Thousand CAD | -109.49% |
| 2012 | 276.83 Thousand CAD | 159.11% |
| 2011 | 106.83 Thousand CAD | 0.0% |
| 2010 | - CAD | 0.0% |
| 2009 | - CAD | 0.0% |
| 2008 | - CAD | 0.0% |
| 2007 | - CAD | 0.0% |
| 2006 | - CAD | 0.0% |
| 2005 | - CAD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 14.92 Thousand CAD | 289.56% |
| 2024 Q1 | -16.17 Thousand CAD | -165.44% |
| 2023 Q4 | 24.72 Thousand CAD | 467.43% |
| 2023 Q1 | -12.91 Thousand CAD | -158.09% |
| 2023 FY | -24.23 Thousand CAD | -141.92% |
| 2023 Q2 | -12.75 Thousand CAD | 1.19% |
| 2023 Q3 | -6728.00 CAD | 47.26% |
| 2022 Q4 | 22.22 Thousand CAD | 49.81% |
| 2022 FY | 57.8 Thousand CAD | 218.43% |
| 2022 Q1 | 23.37 Thousand CAD | 285.93% |
| 2022 Q2 | -2622.00 CAD | -111.22% |
| 2022 Q3 | 14.83 Thousand CAD | 665.79% |
| 2021 Q2 | -12.23 Thousand CAD | -0.95% |
| 2021 Q3 | -11.88 Thousand CAD | 2.92% |
| 2021 FY | -48.81 Thousand CAD | -285.81% |
| 2021 Q4 | -12.56 Thousand CAD | -5.78% |
| 2021 Q1 | -12.12 Thousand CAD | -152.05% |
| 2020 Q2 | - CAD | 0.0% |
| 2020 Q4 | 23.29 Thousand CAD | 682.14% |
| 2020 FY | 26.27 Thousand CAD | -29.33% |
| 2020 Q3 | 2978.00 CAD | 0.0% |
| 2020 Q1 | - CAD | -100.0% |
| 2019 FY | 37.17 Thousand CAD | 41.88% |
| 2019 Q1 | 20.26 Thousand CAD | 1175.58% |
| 2019 Q2 | -1673.00 CAD | -108.26% |
| 2019 Q4 | 20.23 Thousand CAD | 1326.06% |
| 2019 Q3 | -1650.00 CAD | 1.37% |
| 2018 Q2 | -1613.00 CAD | -2.15% |
| 2018 Q1 | -1579.00 CAD | 0.44% |
| 2018 FY | 26.19 Thousand CAD | 2490.33% |
| 2018 Q4 | -1884.00 CAD | -106.02% |
| 2018 Q3 | 31.27 Thousand CAD | 2038.93% |
| 2017 Q4 | -1586.00 CAD | 94.43% |
| 2017 FY | -1096.00 CAD | 96.03% |
| 2017 Q3 | -28.46 Thousand CAD | -69.23% |
| 2017 Q2 | -16.81 Thousand CAD | -50.77% |
| 2017 Q1 | -11.15 Thousand CAD | -193.16% |
| 2016 Q1 | -13.96 Thousand CAD | 18.66% |
| 2016 Q2 | -13.48 Thousand CAD | 3.45% |
| 2016 Q3 | -12.16 Thousand CAD | 9.81% |
| 2016 FY | -27.63 Thousand CAD | -103.21% |
| 2016 Q4 | 11.97 Thousand CAD | 198.46% |
| 2015 Q3 | -8636.05 CAD | -144.52% |
| 2015 FY | -13.6 Thousand CAD | -152.24% |
| 2015 Q1 | -8284.57 CAD | -20811.43% |
| 2015 Q2 | 19.39 Thousand CAD | 334.15% |
| 2015 Q4 | -17.16 Thousand CAD | -98.8% |
| 2014 Q3 | 24.48 Thousand CAD | 410.92% |
| 2014 Q1 | 9654.00 CAD | 116.32% |
| 2014 FY | 26.03 Thousand CAD | 199.09% |
| 2014 Q4 | 40.00 CAD | -99.84% |
| 2014 Q2 | -7874.59 CAD | -181.57% |
| 2013 Q4 | -59.14 Thousand CAD | -219.68% |
| 2013 Q2 | -10.31 Thousand CAD | -62.57% |
| 2013 Q1 | -6345.00 CAD | -1.42% |
| 2013 FY | -26.27 Thousand CAD | -109.49% |
| 2013 Q3 | 49.41 Thousand CAD | 579.1% |
| 2012 FY | 276.83 Thousand CAD | 159.11% |
| 2012 Q3 | 109.29 Thousand CAD | -34.88% |
| 2012 Q2 | 167.84 Thousand CAD | 1356.63% |
| 2012 Q1 | 11.52 Thousand CAD | -68.42% |
| 2012 Q4 | -6256.33 CAD | -105.72% |
| 2011 Q2 | - CAD | 0.0% |
| 2011 FY | 106.83 Thousand CAD | 0.0% |
| 2011 Q4 | 36.48 Thousand CAD | -48.14% |
| 2011 Q3 | 70.35 Thousand CAD | 0.0% |
| 2011 Q1 | - CAD | 0.0% |
| 2010 Q2 | - CAD | 0.0% |
| 2010 Q3 | - CAD | 0.0% |
| 2010 FY | - CAD | 0.0% |
| 2010 Q4 | - CAD | 0.0% |
| 2010 Q1 | - CAD | 0.0% |
| 2009 Q4 | - CAD | 0.0% |
| 2009 FY | - CAD | 0.0% |
| 2009 Q2 | - CAD | 0.0% |
| 2009 Q1 | - CAD | 0.0% |
| 2009 Q3 | - CAD | 0.0% |
| 2008 Q1 | - CAD | 0.0% |
| 2008 Q4 | - CAD | 0.0% |
| 2008 Q2 | - CAD | 0.0% |
| 2008 Q3 | - CAD | 0.0% |
| 2008 FY | - CAD | 0.0% |
| 2007 Q3 | - CAD | 0.0% |
| 2007 Q4 | - CAD | 0.0% |
| 2007 FY | - CAD | 0.0% |
| 2007 Q2 | - CAD | 0.0% |
| 2007 Q1 | - CAD | 0.0% |
| 2006 Q1 | - CAD | 0.0% |
| 2006 Q4 | - CAD | -100.0% |
| 2006 Q3 | 5572.95 CAD | 23.01% |
| 2006 FY | - CAD | 0.0% |
| 2006 Q2 | 4530.34 CAD | 0.0% |
| 2005 FY | - CAD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| AVITA Medical, Inc. | 41.68 Million USD | 99.898% |
| Manhattan Scientifics, Inc. | -1000.00 USD | 4343.4% |
| Össur hf. | 485.57 Million USD | 99.991% |
| QHSLab, Inc. | 793.6 Thousand USD | 94.653% |
| Wellstar International, Inc. | - USD | -Infinity% |
| Össur hf. | 485.57 Million USD | 99.991% |
| CVR Medical Corp. | - USD | -Infinity% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| Escalon Medical Corp. | 5.14 Million USD | 99.175% |
| Aurora Spine Corporation | 8.21 Million USD | 99.483% |
| BrainsWay Ltd. | 23.09 Million USD | 99.816% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| BioElectronics Corporation | 466.38 Thousand USD | 90.902% |
| Hamilton Thorne Ltd. | 35.08 Million USD | 99.879% |
| Vivos Inc. | -6036.00 USD | 803.015% |
| Kelyniam Global, Inc. | 2.03 Million USD | 97.916% |
| REMSleep Holdings, Inc. | -756.73 Thousand USD | 105.607% |
| Zecotek Photonics Inc. | -195.32 Thousand USD | 121.725% |
| Avitar, Inc. | 836.7 Thousand USD | 94.928% |
| Nanomix Corporation | -69.45 Thousand USD | 161.093% |
| EKF Diagnostics Holdings plc | 16.74 Million USD | 99.747% |
| Theraclion SA | -1.08 Million USD | 103.928% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Positron Corporation | -353.46 Thousand USD | 112.005% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 1.04 Million USD | 95.941% |
| Lombard Medical, Inc. | 955 Thousand USD | 95.557% |
| ALR Technologies Inc. | 4945.00 USD | -758.119% |
| Stratec SE | 71.58 Million USD | 99.941% |
| Vycor Medical, Inc. | 1.31 Million USD | 96.775% |
| Heart Tronics, Inc. | - USD | -Infinity% |
| MicroPort Scientific Corporation | 532.09 Million USD | 99.992% |
| VMS Rehab Systems, Inc. | -10.44 USD | 406555.939% |
| NewCardio, Inc. | 105.1 Thousand USD | 59.626% |
| Guided Therapeutics, Inc. | 36 Thousand USD | -17.872% |
| Ingen Technologies, Inc. | 268.57 Thousand USD | 84.2% |
| Odyssey Group International, Inc. | - USD | -Infinity% |
| CYduct Diagnostics, Inc. | 56.59 Thousand USD | 25.02% |
| Wellness Center USA, Inc. | 587.55 Thousand USD | 92.778% |
| SANUWAVE Health, Inc. | 14.36 Million USD | 99.705% |
| IR-Med Inc. | -17 Thousand USD | 349.612% |
| Perimeter Medical Imaging AI, Inc. | 206.41 Thousand USD | 79.443% |
| Polarean Imaging plc | 335.48 Thousand USD | 87.351% |
| United American Healthcare Corporation | -8000.00 USD | 630.425% |
| ECGI Holdings, Inc. | - USD | -Infinity% |
| Nu-Med Plus, Inc. | -12.9 Thousand USD | 428.946% |
| Capital Group Holdings, Inc. | - USD | -Infinity% |
| ADM Tronics Unlimited, Inc. | 1.09 Million USD | 96.121% |
| Medical Supply International USA, Inc. | 1.75 Million USD | 97.587% |
| Urologix, Inc. | 6.09 Million USD | 99.304% |
| Rapid Therapeutic Science Laboratories, Inc. | - USD | -Infinity% |
| Nexeon MedSystems Inc. | -316.69 Thousand USD | 113.399% |
| SS Innovations International, Inc. | 713.44 Thousand USD | 94.052% |
| Qualis Innovations, Inc. | - USD | -Infinity% |
| Smith & Nephew plc | 3.91 Billion USD | 99.999% |
| NIOX Group Plc | 28.13 Million USD | 99.849% |
| Fuse Medical, Inc. | 10.73 Million USD | 99.605% |
| Broncus Holding Corporation | 7.22 Million USD | 99.413% |
| Brain Scientific Inc. | 54.32 Thousand USD | 21.889% |
| Pressure BioSciences, Inc. | 799.56 Thousand USD | 94.693% |
| Health Logic Interactive Inc. | - USD | -Infinity% |